China has approved a new vaccine for the pneumonia-like disease Severe Acute Respiratory Syndrome (SARS) to go through human trials, state media reported .
The vaccine, developed by a Beijing-based inspection and quarantine body, was created in October and is undergoing clinical trials, the China Daily said.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!